新天药业：上半年净利润576.61万元 同比下降80.99%

Core Insights - The company reported a significant decline in revenue and net profit for the first half of 2025 compared to the previous year [1] Financial Performance - The company achieved an operating income of 358 million yuan, representing a year-on-year decrease of 18.88% [1] - The net profit attributable to shareholders of the listed company was 5.77 million yuan, down 80.99% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 3.58 million yuan, reflecting a year-on-year decline of 87.87% [1] - The basic earnings per share were reported at 0.0236 yuan [1]